Found 5 matching trials
A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)
PHASE1The goal of this study is to understand the safety, tolerability and immuno...
Location
Multiple Locations
Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)
PHASE2This study will test the safety and efficacy of an investigational Human Im...
Location
Multiple Locations
A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)
PHASE1This three stage study will evaluate the safety and tolerability of MRKAd5 ...
Location
Multiple Locations
MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)
PHASE1A Study to assess the general safety and tolerability of the administration...
Location
Multiple Locations
A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019)
PHASE1This study is designed to determine whether patients previously primed with...
Location
Multiple Locations